These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36578549)

  • 1. Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis.
    Lin WY; Wang SS; Kang YN; Porpiglia AS; Chang Y; Huang CH; Bhimani R; Abdul-Lattif E; Azmat M; Wang TH; Lin YS; Chang YC; Chi KY
    Front Pharmacol; 2022; 13():1048980. PubMed ID: 36578549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis.
    Chang Y; Lin WY; Chang YC; Huang CH; Tzeng HE; Abdul-Lattif E; Wang TH; Tseng TH; Kang YN; Chi KY
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Up-To-Date Investigation Into the Correlation Between Proton Pump Inhibitor Use and the Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Solid Cancers: A Systematic Review and Meta-Analysis.
    Liu C; Guo H; Mao H; Tong J; Yang M; Yan X
    Front Oncol; 2022; 12():753234. PubMed ID: 35280736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT).
    Kim SY; Lee JS; Kang J; Morita S; Park YS; Sakamoto J; Muro K; Xu RH; Kim TW
    Oncologist; 2021 Jun; 26(6):e954-e962. PubMed ID: 33644953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer.
    Wong GG; Ha V; Chu MP; Dersch-Mills D; Ghosh S; Chambers CR; Sawyer MB
    Clin Colorectal Cancer; 2019 Mar; 18(1):72-79. PubMed ID: 30551953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.
    Chu MP; Hecht JR; Slamon D; Wainberg ZA; Bang YJ; Hoff PM; Sobrero A; Qin S; Afenjar K; Houe V; King K; Koski S; Mulder K; Hiller JP; Scarfe A; Spratlin J; Huang YJ; Khan-Wasti S; Chua N; Sawyer MB
    JAMA Oncol; 2017 Jun; 3(6):767-773. PubMed ID: 27737436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients.
    Sun J; Ilich AI; Kim CA; Chu MP; Wong GG; Ghosh S; Danilak M; Mulder KE; Spratlin JL; Chambers CR; Sawyer MB
    Clin Colorectal Cancer; 2016 Sep; 15(3):257-63. PubMed ID: 26803708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis.
    Guo H; Zhang R; Zhang P; Chen Z; Hua Y; Huang X; Li X
    Front Pharmacol; 2023; 14():1129948. PubMed ID: 37007006
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy.
    Kichenadasse G; Miners JO; Mangoni AA; Karapetis CS; Hopkins AM; Sorich MJ
    J Natl Compr Canc Netw; 2021 May; 19(9):1037-1044. PubMed ID: 33951613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between proton pump inhibitor use and systemic anti-tumour therapy on survival outcomes in patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.
    Wei N; Zheng B; Que W; Zhang J; Liu M
    Br J Clin Pharmacol; 2022 Jul; 88(7):3052-3063. PubMed ID: 35165922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysis.
    Li C; Xia Z; Li A; Meng J
    Ann Transl Med; 2020 Dec; 8(24):1655. PubMed ID: 33490167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do proton pump inhibitors affect the effectiveness of cyclin-dependent kinase 4/6 inhibitors in advanced HR positive, HER2 negative breast cancer? A meta-analysis.
    de Moraes FCA; Pereira CRM; Sano VKT; Laia EA; Stecca C; Burbano RMR
    Front Pharmacol; 2024; 15():1352224. PubMed ID: 38769999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and colorectal cancer: A systematic review.
    Patel A; Spychalski P; Antoszewska M; Regula J; Kobiela J
    World J Gastroenterol; 2021 Nov; 27(44):7716-7733. PubMed ID: 34908809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
    Chen B; Yang C; Dragomir MP; Chi D; Chen W; Horst D; Calin GA; Li Q
    Ther Adv Med Oncol; 2022; 14():17588359221111703. PubMed ID: 35860836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis.
    Lopes S; Pabst L; Dory A; Klotz M; Gourieux B; Michel B; Mascaux C
    Front Immunol; 2023; 14():1070076. PubMed ID: 36776847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.
    Hoon SN; Lau PK; White AM; Bulsara MK; Banks PD; Redfern AD
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011220. PubMed ID: 34037241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Chang YC; Song J; Chang Y; Huang CH; Sudan A; Chen PC; Chi KY
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding.
    Neumann I; Letelier LM; Rada G; Claro JC; Martin J; Howden CW; Yuan Y; Leontiadis GI
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007999. PubMed ID: 23760821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Gastric Acid Suppressant Use on the Safety and Effectiveness of EGFR-TKIs: A Systematic Review and Meta-Analysis.
    Du X; Liu W; Chen K; Wang Z; Li X; Yang L; Xie X
    Front Pharmacol; 2022; 13():796538. PubMed ID: 35795555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.